Corient Private Wealth LLC increased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 5.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 601,849 shares of the biopharmaceutical compan